---
title: "Central and Eastern Europe Fund's Glen increased its holdings in Haisco and Pharmaron in the third quarter, but strong performance still fails to prevent net redemptions"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263111196.md"
description: "ZhongOu Fund's investment director, Ge Lan, has two pharmaceutical-themed funds that both rose over 20% in the third quarter, but still faced the highest net redemptions since their inception. The stock position of ZhongOu Healthcare has increased to 94.56%, with first-time purchases of Haisco and increased holdings in Pharmaron, among others. Despite the excellent performance of the three funds, they continue to experience net redemptions, particularly ZhongOu Healthcare, which saw redemptions of 2.342 billion shares. Ge Lan is optimistic about the long-term investment value of the pharmaceutical industry, believing that the fields of innovative drugs, medical devices, and consumer healthcare still have potential"
datetime: "2025-10-28T13:56:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263111196.md)
  - [en](https://longbridge.com/en/news/263111196.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263111196.md)
generator: "portal-rs"
---

# Central and Eastern Europe Fund's Glen increased its holdings in Haisco and Pharmaron in the third quarter, but strong performance still fails to prevent net redemptions

On October 28th, Gran disclosed the third-quarter report for 2025 for the funds under management. In terms of stock positions, the stock position of China Europe Medical Health reached a historical high, rising to 94.56%. In terms of performance, during the third quarter, all three funds managed by Gran significantly outperformed the performance benchmark for the same period. Among them, China Europe Mingrui New Starting Point made nearly 60% profit in the third quarter. However, it is worth noting that all three funds continued to experience net redemptions, with China Europe Medical Health and China Europe Medical Innovation facing the highest redemption amounts since their inception. (The Paper)

### Related Stocks

- [300759.CN](https://longbridge.com/en/quote/300759.CN.md)
- [03759.HK](https://longbridge.com/en/quote/03759.HK.md)
- [002653.CN](https://longbridge.com/en/quote/002653.CN.md)

## Related News & Research

- [Tesla-SpaceX Merger Stands at 80%-90% Chance, Dan Ives' $500 Price Tag Explains Why](https://longbridge.com/en/news/303112286.md)
- [Verizon CEO Says SpaceX May Be Years Away From Becoming America's 'Sixth' Wireless Competitor](https://longbridge.com/en/news/303109070.md)
- [I'd Buy Half a Position in Amazon Stock Before Its Oct. 29 Report -- and Half After](https://longbridge.com/en/news/303054275.md)
- [AppLovin Corporation $APP Stock Purchased by Hedeker Wealth LLC](https://longbridge.com/en/news/303049441.md)
- [Moderna, Inc. $MRNA Shares Sold by IFP Advisors Inc](https://longbridge.com/en/news/303041682.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**